TGFB1 and liver disorder: Signaling reporter assay revealed that NP-011 rapidly suppressed TGF-β signaling within 30 min, whereas Milk fat globule-EGF factor 8 (MFG-E8) could suppress TGF-β signaling 2 h after treatment (Figure 4A), implying the enhanced capacity of NP-011 for inhibiting TGF-β signaling in liver disease.